‘Text/HTML’ of page ‘NRG-LU007: The RAPTOR Study for ES-SCLC’
Frequently Asked Questions Below, you can find FAQs about clinical research and this particular clinical trial.
Read MoreContent Block Tag: NRG-LU007: The RAPTOR Study for ES-SCLC
‘Text/HTML’ of page ‘NRG-LU007: The RAPTOR Study for ES-SCLC’
Am I eligible for this study? If you over the age of 18 with extensive stage small cell lung cancer, you may be able to participate. Your healthcare team is the best source for information about your treatment options, including cancer clinical trials. Be sure to take this information to your doctor to discuss your […]
Read More‘Text/HTML’ of page ‘NRG-LU007: The RAPTOR Study for ES-SCLC’
About This Study NRG-LU007, also known as “the RAPTOR study”, is a clinical study for people with extensive stage small cell lung cancer (SCLC) that is testing if adding radiation therapy to the usual treatment can extend the time without your cancer growing or spreading. Typically, people with extensive stage SCLC are treated initially […]
Read More‘Text/HTML’ of page ‘NRG-LU007: The RAPTOR Study for ES-SCLC’
Clinical Studies FAQ
Read More‘Text/HTML’ of page ‘NRG-LU007: The RAPTOR Study for ES-SCLC’
The RAPTOR Study FAQ
Read More